Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-022655)

Filing Details

Accession Number:: 0000950170-25-022655
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-18 19:31:27
Reporting Period:: 2025-02-18

Filing Date:: 2025-02-18
Accepted Time:: 2025-02-18 19:31:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501796	Aura Biosciences Inc.	AURA	Biological Products, (No Disgnostic Substances) (2836)	320271970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1868719	Mark Plavsic	C/O Aura Biosciences, Inc. 80 Guest Street Boston MA 02135	Chief Technology Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-02-18	2,151	$7.75	209,456	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.